figshare
Browse
1-s2.0-S016781401830793X-main.pdf (586.92 kB)

The REQUITE project: integrating biomarkers and clinical predictors of radiotherapy side effects

Download (586.92 kB)
conference contribution
posted on 2019-02-12, 15:58 authored by Christopher Talbot, D Azria, T Burr, J Chang-Claude, A Dunning, C Herskind, D De Ruysscher, R Elliott, S Gutierrez-Enriquez, P Lambin, A Mueller, T Rancati, B Rosenstein, T Rattay, P Seibold, L Veldeman, A Vega, F Wenz, R Valdagni, A Webb, C West
The European Union funded REQUITE consortium aims to validate predictors of radiotherapy-related adverse reactions to develop clinically useful tools. Potential predictors include clinical and dose parameters, genetic markers, gene expression and the radiation-induced lymphocyte apoptosis (RILA).

History

Citation

Radiotherapy and Oncology, 2018, 127 (Supplement 1), pp. S248-S249

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/Biological Sciences/Genetics and Genome Biology

Source

The 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, SPAIN

Version

  • VoR (Version of Record)

Published in

Radiotherapy and Oncology

Publisher

Elsevier for European Society for Therapeutic Radiology and Oncology

issn

0167-8140

eissn

1879-0887

Copyright date

2018

Available date

2019-02-12

Publisher DOI

Publisher version

https://www.sciencedirect.com/science/article/pii/S016781401830793X?via=ihub

Temporal coverage: start date

2018-04-20

Temporal coverage: end date

2018-04-24

Language

en

Administrator link

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Keywords

    Science & TechnologyLife Sciences & BiomedicineOncologyRadiology, Nuclear Medicine & Medical Imaging

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC